Olympus Financial Statements From 2010 to 2024

OCPNF Stock  USD 16.00  0.00  0.00%   
Olympus financial statements provide useful quarterly and yearly information to potential Olympus investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Olympus financial statements helps investors assess Olympus' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Olympus' valuation are summarized below:
Olympus does not presently have any trending fundamental ratios for analysis.
Check Olympus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Olympus' main balance sheet or income statement drivers, such as , as well as many indicators such as . Olympus financial statements analysis is a perfect complement when working with Olympus Valuation or Volatility modules.
  
This module can also supplement various Olympus Technical models . Check out the analysis of Olympus Correlation against competitors.

Olympus Company Return On Equity Analysis

Olympus' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Olympus Return On Equity

    
  0.23  
Most of Olympus' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Olympus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Olympus has a Return On Equity of 0.2329. This is 100.97% lower than that of the Healthcare sector and 103.89% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 175.13% lower than that of the firm.

Olympus Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Olympus's current stock value. Our valuation model uses many indicators to compare Olympus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Olympus competition to find correlations between indicators driving Olympus's intrinsic value. More Info.
Olympus is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.35  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Olympus is roughly  2.86 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Olympus' earnings, one of the primary drivers of an investment's value.

About Olympus Financial Statements

Olympus stakeholders use historical fundamental indicators, such as Olympus' revenue or net income, to determine how well the company is positioned to perform in the future. Although Olympus investors may analyze each financial statement separately, they are all interrelated. For example, changes in Olympus' assets and liabilities are reflected in the revenues and expenses on Olympus' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Olympus. Please read more on our technical analysis and fundamental analysis pages.
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan. Olympus Corp operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31557 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Olympus Pink Sheet

Olympus financial ratios help investors to determine whether Olympus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Olympus with respect to the benefits of owning Olympus security.